Instituto Bioclon S.A. de C.V.

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Instituto Bioclon S.A. de C.V. sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 8 completed upper quartile by trial count

Instituto Bioclon S.A. de C.V.: 8 sponsored US clinical trials, none currently recruiting.

Instituto Bioclon S.A. de C.V. sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 3 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Snake Bite, with 1 trials.

Upper-quartile sponsor footprint

Instituto Bioclon S.A. de C.V. sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

COMPLETED Phase 3

Black Widow Spider Antivenin for Patients With Systemic Latrodectism

NCT00657540
COMPLETED Phase 3

Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

NCT00636116
COMPLETED Phase 2

The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism

NCT00247078
COMPLETED Phase 2

Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation

NCT00624078
COMPLETED Phase 2

A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,

NCT00868309
COMPLETED

Establishment of Natural History of Scorpion Envenomation

NCT00696683
COMPLETED Phase 2

Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients

NCT00685230
COMPLETED Phase 3

Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation

NCT01599936

Phase Distribution

PhaseTrial count
Phase 2 4
Phase 3 3

Therapeutic Areas

Snake Bite 1
Latrodectism 1
Arachnidism 1
Blood Coagulation Disorders 1

How the Instituto Bioclon S.A. de C.V. archive is shaped

8 indexed studies, none listed as recruiting (0% open); 8 completed (100%).

Phase mix: 3 late (III/IV) vs 4 early (I/II) (balanced across stages).

Top condition: Snake Bite (1 trial), 3 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Instituto Bioclon S.A. de C.V.: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Instituto Bioclon S.A. de C.V. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Instituto Bioclon S.A. de C.V.AB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
Instituto Bioclon S.A. de C.V. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Instituto Bioclon S.A. de C.V. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Instituto Bioclon S.A. de C.V. page

8 registered trials is a research-attention snapshot, not an endorsement of Instituto Bioclon S.A. de C.V. or any single study.

  • None of Instituto Bioclon S.A. de C.V.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Snake Bite is the condition Instituto Bioclon S.A. de C.V. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Snake Bite trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Instituto Bioclon S.A. de C.V. pipeline card: 8 registered trials from official public datasets.Report a data error.